Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for status epilepticus.

T P Bleck

    Clinical Neuropharmacology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Recent advances in understanding status epilepticus (SE) pathophysiology drive urgent research. This review covers anticonvulsant pharmacology for treating SE and explores future therapeutic potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cerebrovascular Autoregulation Monitoring in the Management of Adult Severe Traumatic Brain Injury: A Delphi Consensus of Clinicians.

    Neurocritical care·2021
    Same author

    Research priorities in neurocritical care.

    Neurocritical care·2011
    Same author

    Report of a National Conference on Donation after cardiac death.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
    Same author

    Changes in severe accidental tetanus mortality in the ICU during two decades in Brazil.

    Intensive care medicine·2002
    Same author

    Critical care neurology.

    American journal of respiratory and critical care medicine·2001
    Same author

    Propofol and midazolam in the treatment of refractory status epilepticus.

    Epilepsia·2001
    Same journal

    Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

    Clinical neuropharmacology·2026
    Same journal

    A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

    Clinical neuropharmacology·2026
    Same journal

    Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

    Clinical neuropharmacology·2026
    Same journal

    Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

    Clinical neuropharmacology·2026
    Same journal

    Letter to the Editor on Multifocal Myoclonus Associated With Trimethoprim-Sulfamethoxazole: A Case Report.

    Clinical neuropharmacology·2026
    Same journal

    Clozapine Induced Myocarditis and Pericarditis: An Analysis of Two Illustrative Cases.

    Clinical neuropharmacology·2026
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology
    • Epilepsy Research

    Background:

    • Status epilepticus (SE) is a critical neurological condition.
    • Advances in understanding SE pathophysiology necessitate updated treatment strategies.

    Purpose of the Study:

    • To review the clinical pharmacology of anticonvulsants used in treating SE.
    • To discuss the application of these drugs across different SE types.
    • To consider future research directions in SE treatment.

    Main Methods:

    • Literature review of current research on SE pathophysiology.
    • Analysis of clinical pharmacology data for relevant anticonvulsants.
    • Discussion of treatment applications and future prospects.

    Main Results:

    Related Experiment Videos

    • Key anticonvulsants and their mechanisms of action in SE are detailed.
    • Specific treatment approaches for various SE subtypes are outlined.
    • Identified gaps and opportunities for future SE research.

    Conclusions:

    • Effective management of SE relies on understanding anticonvulsant pharmacology.
    • Tailored treatment strategies are crucial for different SE types.
    • Continued research is essential for advancing SE therapies.